|
PSPC1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.062000E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.648230E-02 |
| Normal-vs-Stage2 |
1.660230E-03 |
| Normal-vs-Stage3 |
3.275500E-03 |
| Normal-vs-Stage4 |
7.63420000000625E-05 |
| Stage1-vs-Stage2 |
5.988200E-02 |
| Stage1-vs-Stage3 |
2.818200E-01 |
| Stage1-vs-Stage4 |
1.350450E-02 |
| Stage2-vs-Stage3 |
3.254400E-01 |
| Stage2-vs-Stage4 |
8.694600E-01 |
| Stage3-vs-Stage4 |
2.625400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.159400E-03 |
| Normal-vs-AfricanAmerican |
5.919400E-01 |
| Normal-vs-Asian |
5.508200E-02 |
| Caucasian-vs-AfricanAmerican |
1.337210E-01 |
| Caucasian-vs-Asian |
6.090400E-01 |
| AfricanAmerican-vs-Asian |
3.132000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.207500E-04 |
| Normal-vs-Female |
5.844900E-03 |
| Male-vs-Female |
3.176200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.923700E-02 |
| Normal-vs-Age(41-60Yrs) |
3.898600E-03 |
| Normal-vs-Age(61-80Yrs) |
1.840820E-04 |
| Normal-vs-Age(81-100Yrs) |
5.099800E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.975370E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.430050E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.549400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.018800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.654200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.633000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.965200E-01 |
| Classical-VS-Follicular |
3.71289999999691E-05 |
| Classical-VS-Other |
1.809600E-01 |
| Classical-VS-Normal |
5.402300E-02 |
| Tall-VS-Follicular |
2.694100E-02 |
| Tall-VS-Other |
3.875000E-01 |
| Tall-VS-Normal |
4.952500E-02 |
| Follicular-VS-Other |
7.504000E-01 |
| Follicular-VS-Normal |
2.07679999999488E-05 |
| Other-VS-Normal |
5.743900E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.241500E-04 |
| Normal-vs-N1 |
8.361800E-03 |
| N0-vs-N1 |
7.037400E-01 |
|
|
